Biologics
Insmed Advances Follow on Biologics Initiative
Published in Medical Patent Week, December 2nd, 2007
Insmed Inc. (Nasdaq:INSM), a biopharmaceutical company with unique protein process development and manufacturing experience and a proprietary protein platform aimed at niche markets with unmet medical needs, announced the completion of development of two key follow on biologics at its facilities in Boulder, Colorado. The development of INS-19 (Granulocyte Colony Stimulating Factor or G-CSF) and INS-20 (Peg G-CSF) represents a significant milestone for Insmed. By achieving these critical development milestones, Insmed is positioned to initiate clinical studies in the first half of 2008.
Insmed is at the forefront in the United States for the development of follow on...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
Source: Medical Patent Week (2007-12-02)
More Articles from Medical Patent Week
- Alzheimer Disease
The CNS Market Outlook to 2012 is a New Report That Provides a Detailed Epidemiological Analysis of Major Indications Within the CNS Disorders Market - Biotechnology
Nymox Reports Third Quarter Financial Results for 2007 - Biotechnology
Phage Biotechnology Corp. Engages the Bruckner Group to Find a Joint Commercialization Partner for Phage's Portfolio of Recombinant Protein Biopharmaceuticals, Technologies, and Development Platforms - Biotechnology
Pure H20 Bio-Technologies Approves Forward Split of Its Common Stock - Cancer Vaccines
ImmunoCellular Therapeutics Names Interim President, Files Key Patent Applications - Chronic Kidney Failure
FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing - More from this issue of Medical Patent Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
